Irene Mesa-Rebollo - Publications

Two phase 1 randomised studies investigating the safety and pharmacokinetics of bepranemab in healthy participants of different ethnicities.

Journal: BMJ neurology open

Published: October 03, 2025

Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trial.

Journal: BMJ neurology open

Published: October 01, 2025

Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: October 01, 2024

Combined Assessment of Function and Survival to Demonstrate the Effect of Treatment on Progressive Supranuclear Palsy.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 05, 2024

Ex vivo delivery of Mirococept: A dose-finding study in pig kidney after showing a low dose is insufficient to reduce delayed graft function in human kidney.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 31, 2020

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy.

Journal: EBioMedicine

Published: May 16, 2020

Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: October 03, 2019

Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies.

Journal: Trials

Published: March 28, 2019

Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples.

Journal: EBioMedicine

Published: August 19, 2018

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.

Journal: Frontiers in aging neuroscience

Published: December 21, 2017

Steroid regulation: An overlooked aspect of tolerance and chronic rejection in kidney transplantation.

Journal: Molecular and cellular endocrinology

Published: July 22, 2017

Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 30, 2017